Modulation of immune responses with transcutaneously deliverable adjuvants.
Transcutaneous immunisation is a novel vaccination strategy based on the application of antigen together with an adjuvant onto hydrated bare skin. This simple and non-invasive immunisation procedure elicits systemic and mucosal immune responses and therefore, it provides a viable and cost-effective strategy for disease prevention. For the induction of antigen-specific immune responses the use of adjuvants is critical. They potentiate and modulate the type of immune responses by stimulating the production of cytokines that drive the differentiation of T cells towards the Th1 or Th2-phenotype. These cells mediate protection against different infectious diseases and therefore, their selective induction is important for successful vaccination. In this review we give a brief overview of transcutaneously deliverable adjuvants and we discuss how they modulate immune responses to topically applied antigens.
Partidos
Charalambos D
CD
UPR 9021, Immunologie et Chimie Thérapeutiques, Institut de Biologie Moléculaire et Cellulaire, CNRS, 15 rue René Descartes, F-67084 Strasbourg, France. H.Partidos@ibmc.u-strasbg.fr
Beignon
Anne-Sophie
AS
Briand
Jean-Paul
JP
Muller
Sylviane
S
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000279:Administration, Cutaneous; D000917:Antibody Formation / Q000187:drug effects* / Q000276:immunology; D007111:Immunity, Cellular / Q000187:drug effects* / Q000276:immunology; D010455:Peptides / Q000008:administration & dosage; D014612:Vaccines / Q000276:immunology*
D000276:Adjuvants, Immunologic; D010455:Peptides; D014612:Vaccines